These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7877517)

  • 1. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study.
    Schmidt JB; Binder M; Macheiner W; Kainz C; Gitsch G; Bieglmayer C
    Maturitas; 1994 Nov; 20(1):25-30. PubMed ID: 7877517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of skin aging with topical estrogens.
    Schmidt JB; Binder M; Demschik G; Bieglmayer C; Reiner A
    Int J Dermatol; 1996 Sep; 35(9):669-74. PubMed ID: 8876303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When applied to facial skin, does estrogen ointment have systemic effects?
    Kainz C; Gitsch G; Stani J; Breitenecker G; Binder M; Schmidt JB
    Arch Gynecol Obstet; 1993; 253(2):71-4. PubMed ID: 8215610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study.
    Holzer G; Riegler E; Hönigsmann H; Farokhnia S; Schmidt JB
    Br J Dermatol; 2005 Sep; 153(3):626-34. PubMed ID: 16120154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of hormone replacement therapy on skin ageing: a pilot study.
    Sator PG; Schmidt JB; Sator MO; Huber JC; Hönigsmann H
    Maturitas; 2001 Jul; 39(1):43-55. PubMed ID: 11451620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin.
    Schmidt JB; Binder M; Macheiner W; Bieglmayer C
    Int J Dermatol; 1995 Jan; 34(1):53-7. PubMed ID: 7896490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Double-Blind Randomized Pilot Study Evaluating the Safety and Efficacy of Topical MEP in the Facial Appearance Improvement of Estrogen Deficient Females.
    Draelos ZD
    J Drugs Dermatol; 2018 Nov; 17(11):1186 - 1189. PubMed ID: 30500138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
    Barentsen R; van de Weijer PH; Schram JH
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
    Masuda Y; Hirao T; Mizunuma H
    J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study.
    Patriarca MT; Goldman KZ; Dos Santos JM; Petri V; Simões RS; Soares JM; Simões MJ; Baracat EC
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):202-5. PubMed ID: 16797821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a new transdermal delivery system for estrogen replacement therapy in postmenopausal women.
    Figueroa-Casas PR; Alfonsin A; Arrighi A; Bluvstein G; Del Castillo R; Goldsman T; Inglesi J; Itala J; Novelli J; Monti C
    Maturitas; 1994 Dec; 20(2-3):139-44. PubMed ID: 7715465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen therapy on climacteric symptoms and tissue changes.
    Punnonen R; Rauramo L
    Acta Obstet Gynecol Scand; 1974; 53(3):267-9. PubMed ID: 4843720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
    Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M
    Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of percutaneous absorption performance for human female sexual steroids into pentravan cream.
    Polonini HC; Brandão MA; Ferreira AO; Ramos C; Raposo NR
    Int J Pharm Compd; 2014; 18(4):332-40. PubMed ID: 25474862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.